Recent studies demonstrated that Fusobacterium nucleatum, a gram-negative bacterial antigen, can activate a toll-like receptor 4 (TLR4)/myeloid differentiation primary response protein 88 (MYD88) cascade, thereby increasing the progression and chemoresistance of colorectal cancer [15, 20]. The gene discussed is MYD88; the disease is colorectal cancer.